Literature DB >> 3942172

Corneal changes during pilocarpine gel therapy.

D H Johnson, K R Kenyon, D L Epstein, E M Van Buskirk.   

Abstract

Fifteen of 53 patients (28%) receiving long-term pilocarpine gel therapy were noted to have a subtle, diffuse superficial corneal haze. Results of a masked examination of patients using pilocarpine gel vs pilocarpine eyedrops and the finding of the haze unilaterally in patients using the gel unilaterally suggested that the haze is related to the pilocarpine gel. In most patients the haze persisted for two years after gel treatment was discontinued; the haze disappeared in two patients. Although patients remain asymptomatic with unaltered visual acuities, the long-term effect of this corneal change is unknown.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942172     DOI: 10.1016/0002-9394(86)90459-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

3.  The effects of long-term topical glaucoma medication on conjunctival impression cytology.

Authors:  E Turaçli; K Budak; A Kaur; B Mizrak; C Ekinci
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

Review 4.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

5.  Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density.

Authors:  S Nagasubramanian; R H Stewart; R A Hitchings
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.